Articles tagged “Category 2”
3 articles
What Category 2 Removal Actually Means (And What It Doesn't)
The FDA removed 12 peptides from Category 2 in April 2026. Many people think this means they're legal to compound. It doesn't. Here's the critical legal nuance that most sources are getting wrong.
May 1, 20265 min readregulatory
The History of Peptide Regulation: From the 2023 Ban to the 2026 Reversal
How 19 peptides went from legally compoundable to banned to partially restored in three years — a timeline of the most turbulent period in peptide regulatory history.
April 22, 20267 min readregulatory
FDA Removes 12 Peptides from Category 2: What It Actually Means
On April 15, 2026, the FDA announced that 12 peptides — including BPC-157, TB-500, Semax, and Epitalon — will exit the Category 2 restricted list on April 22. Here's a clear breakdown of what changed, what didn't, and what happens next.
April 16, 20266 min readregulatory
All Tags
503A503BAOD-9604BDNFBPC-157BremelanotideCJC-1295COACategory 1Category 2DihexaEgriftaEmideltideEpitalonEpithalonFDAFSAGHK-CuGHRHGIPGLP-1HPLCHSAHims & HersIpamorelinJuly 2026KPVLL-37MOTS-cMOTs-cMedicareMounjaroOzempicPCACPT-141RetatrutideRussiaSelankSemaxTB-500TesamorelinThymosin Alpha-1agingalpha-MSHanalysisanalytical chemistryangiotensin IVanti-aginganti-inflammatoryantimicrobial peptideanxiolyticbacteriostatic waterbeginnerbeginner guidebiohackingbloodworkbudgetcathelicidinclinicclinicscognitivecognitive enhancementcomparisoncompetitioncompoundingcompounding pharmacyconsultationcostcoveragedatadosingeconomicsexercisefakefertilityfinding a doctorfunctional medicineglucagongrowth hormonegut healthhealinghistoryhormoneshow toinjectioninnate immunityinsulin sensitivityinsuranceipamorelinlegallegal risklegitimatelipodystrophymarketmelanocortinmenopausemetabolismmitochondriamitochondrial peptideneuroprotectionnootropicpatient advocacypeptide guidepeptide protocolspharmaceutical-gradepharmacyphysicianpineal glandpricingprior authorizationprotocolspublic commentpurityqualityreclassificationreconstitutionrecoveryred flagsregulationregulatoryresearchretatrutidesafetysemaglutidesermorelinsexual dysfunctionside effectsstackingstoragetelehealthtelomerasetirzepatidetriple agonisttuftsinvaluevendor verificationvisceral fatweight losswhat iswomen